Filing Details
- Accession Number:
- 0001185185-24-000924
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-27 16:05:18
- Reporting Period:
- 2024-09-25
- Accepted Time:
- 2024-09-27 16:05:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1326205 | Igc Pharma Inc. | IGC | Pharmaceutical Preparations (2834) | 202760393 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1907094 | P James Moran | 10224 Falls Road Potomac MD 20854 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-09-25 | 588,235 | $0.34 | 942,402 | No | 4 | P | Indirect | See footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | See footnote |
Footnotes
- Represents shares of IGC Pharma, Inc. ("IGC") common stock purchased directly from IGC by Moran Global Strategies, Inc ("MGS"), a Virginia corporation that is owned by James Moran a director of IGC, subject to the terms and conditions set forth in the 2024 Share Purchase Agreement filed with the SEC on Form 8-K on September 25, 2024. The Reporting Person hereby disclaims beneficial ownership of all securities, except to the extent of any indirect pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Billionaire Hedge Funds
